精神分裂症相关功能性非编码变异分子调控机制
该研究采用功能基因组学方法,从精神分裂症(SCZ)GWAS报道的风险位点中系统鉴定功能性变异。整合ChIP-Seq与PWM数据鉴定出249个影响转录因子结合的功能性变异(位于99个位点),eQTL注释显示207个影响TF结合的SNP与脑内基因表达显著相关。研究为将遗传发现转化为疾病生物学与潜在治疗靶点提供了起点。
要点
- 整合ChIP-Seq与PWM从SCZ风险位点鉴定249个影响TF结合的功能性变异,位于99个位点。
- eQTL注释显示207个影响TF结合的SNP与人类脑内基因表达显著相关。
- 35个功能性变异的调控效应经已发表MPRA验证,SCZ病例中相关基因表达失调。
核心结论
- 研究从已报道的SCZ风险位点中鉴定出功能性非编码变异,并阐明其分子调控机制,为遗传发现向疾病生物学与潜在治疗靶点转化提供起点。
研究设计与样本
- 采用功能基因组学方法,整合ChIP-Seq与位置权重矩阵(PWM)数据,从GWAS报道的SCZ风险位点中系统鉴定功能性变异。
- 对92个未通过功能基因组学鉴定出功能性变异的位点,进行精细定位并应用motifbreakR鉴定潜在因果或功能性变异。
主要发现
- 鉴定出249个影响转录因子(TF)结合的功能性变异,位于99个位点。
- eQTL注释显示207个影响TF结合的SNP与人类脑内基因表达显著相关。
- 35个已鉴定功能性变异的调控效应经已发表的大规模并行报告基因检测(MPRA)验证。
- 表达分析显示,与功能性变异相关的基因在SCZ病例中较对照存在表达失调。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome-wide association studies (GWAS) have identified over 300 risk loci for schizophrenia (SCZ). However, given the vast majority of risk variants identified from GWAS are localized in non-coding regions, identification of functional risk variants from the risk loci and elucidating their molecular regulatory mechanisms remain major challenges. Here, we leverage a functional genomics approach to systematically identify functional variants from the reported risk loci. By integrating chromatin immunoprecipitation sequencing (ChIP-Seq) and position weight matrix (PWM) data, we identified 249 functional variants (located in 99 loci) that affect the binding of transcription factors (TFs). Expression quantitative trait loci (eQTL) annotation showed that 207 TF binding-affecting SNPs are significantly associated with gene expression in the human brain. For 92 loci where functional variants have not been identified by functional genomics, we conducted fine-mapping and applied motifbreakR to identify potential causal or functional variants. Notably, regulatory effects of 35 identified functional variants were validated by the published massively parallel reporter assays (MPRAs). Expression analysis showed dysregulation of genes whose expression levels are associated with functional variants in SCZ cases compared with controls. Our study identifies the functional variants from the reported risk loci and elucidates the molecular regulatory mechanisms of SCZ-associated functional non-coding variants, providing an important starting point to translate the genetic findings into disease biology and potential therapeutic targets.
引用
- Dai SS, Dang X, Gong D, et al. Molecular regulatory mechanisms of schizophrenia-associated functional non-coding variants. Mol Psychiatry. 2026. PMID: 41927765. doi:10.1038/s41380-026-03566-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。